Anzeige
❌
Mehr »
Donnerstag, 15.10.2026 - Börsentäglich über 12.000 News
500.000 USD Mindestabnahme! Small-Cap-Aktie noch unter dem Radar
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
SM

WKN: A3DJVB | ISIN: FR0014005I80 | Ticker-Symbol: G3O
Stuttgart
15.10.26 | 08:55
5,020 Euro
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
S.M.A.I.O SA Chart 1 Jahr
5-Tage-Chart
S.M.A.I.O SA 5-Tage-Chart
RealtimeGeldBriefZeit
5,4205,64009:38

Aktuelle News zur S.M.A.I.O SA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
Leser Medien
DiSMAIO Reports First-Half 2026 Results and Sales for the Third Quarter of 2026375Half-year sales rose by 3% to €5.1m, driven by implant sales in the United States, which increased by 3% to €3.9m (up 10% to $4.5m, excluding currency effects) Solid gross margin of 81%...
► Artikel lesen
06.10.SMAIO Signs a New Collaboration for its KEOPS-4ME Open Platform in the United States413This new agreement marks the acceleration of SMAIO's collaborative strategy aimed at rolling out its open platform for customized implant solutions in the US market. Regulatory News: SMAIO...
► Artikel lesen
03.09.SMAIO has Reappointed Dr Donald J. Blaskiewicz to its Scientific Advisory Board in the United States459Regulatory news: SMAIO (Software, Machines and Adaptative Implants in Orthopaedics Euronext Growth Paris, ISIN code: FR0014005I80 Ticker: ALSMA, PEA-PME eligible), a French-American company specialized...
► Artikel lesen
16.07.SMAIO Reports Sales for the First Half of 2026460Up 3% to €5.1m, first-half sales exceeded the €5m mark for the first time, despite four months of temporary absence of one of the top-performing surgeons in the United States U.S. sales...
► Artikel lesen
12.05.SMAIO Reported Revenue of €2.8 Million in the First Quarter of 2026, an Increase of 11%483Revenue in the United States reached a record quarterly high of €2.3 million (+21%), or $2.6 million (+35%)1 excluding currency effects The United States accounts for nearly 80% of the...
► Artikel lesen
S.M.A.I.O SA Aktie jetzt für 0€ handeln
11.05.SMAIO Expands Its North American Scientific Advisory Board With a New Renowned Surgeon427Appointment of Dr. Jeffrey M. Hills, an orthopedic surgeon specializing in complex spinal conditions SMAIO's Scientific Advisory Board, now comprised of five members, is a key asset in...
► Artikel lesen
05.05.SMAIO Announces that Portzamparc (BNP Paribas Group) has Initiated Coverage of its Stock with a Buy Rating554Regulatory News: SMAIO (Software, Machines and Adaptive Implants in Orthopaedics Euronext Growth Paris, ISIN Code: FR0014005I80 Ticker: ALSMA), a French-American company specialized in complex...
► Artikel lesen
06.03.SMAIO Announces a €3.6 Million Capital Increase to Support Its Long-Term Growth Momentum669Capital increase totaling €3.6 million gross through the issuance of shares with stock warrants (ABSAs) at a price of €7 per share 4 warrants will entitle the holder to subscribe for one...
► Artikel lesen
20.01.SMAIO Reports 2025 Sales of €9.2m, Representing an Increase of +67%520U.S. sales rose by +138% to €7m, and by +160% to $7.9m (excluding currency effects). Strong growth across North American centers that were already active in 2024 (+130%). 11 new...
► Artikel lesen
08.01.SMAIO: 2026 Financial Calendar632Regulatory News: SMAIO (Software, Machines and Adaptive Implants in Orthopaedics Euronext Growth Paris, ISIN: FR0014005I80 Ticker: ALSMA), a French-American player specialized in complex spine...
► Artikel lesen
06.01.SMAIO Obtains €2.0m in Non-Dilutive Financing582€1.0m in the form of a 0% interest loan co-financed by the European Union, the Auvergne-Rhône-Alpes Region and Bpifrance, with a repayment deferral period of two and a half years €1.0m...
► Artikel lesen
19.12.25SMAIO Successfully Continues Its Think Tanks Focused on Promoting Its Innovative Solutions in the United States857New attendance record at the New York session, bringing together nearly 60 experts from the spine sector, including over 40 surgeons Regulatory News: SMAIO (Software, Machines and Adaptative...
► Artikel lesen
24.11.25SMAIO Appoints Matthieu Ville as Chief Commercial Officer to Accelerate Commercialization and Strengthen Its Leadership in Spinal Realignment433Matthieu Ville brings over 15 years of experience in medical marketing in the United States. Regulatory News: SMAIO (Software, Machines and Adaptative Implants in Orthopaedics- Euronext Growth...
► Artikel lesen
03.11.25SMAIO Adds a New High-Profile Member to Its Scientific Advisory Board in the United States496Appointment of Dr. Tenner Guillaume, Orthopaedic spine surgeon who specializes in spinal deformity at Gillette Children's Hospital (St. Paul, Minnesota). SMAIO's US scientific advisory board...
► Artikel lesen
22.10.25SMAIO Signs a New Distribution Agreement for Its Open Platform KEOPS-4ME With Orthofix in the U.S.650Orthofix is a global medical technology company focused on healing musculoskeletal pathologies The distribution arrangement is part of SMAIO's collaborative strategy aimed at deploying...
► Artikel lesen
15 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1